The European Commission has conditionally approved, on Thursday 11 July, the acquisition of Pfizer's Consumer Health Business by GlaxoSmithKline (GSK).
Both GSK and Pfizer's Consumer Health Business are manufacturers and suppliers of a variety of consumer pharmaceutical products active in the European Economic Area (EEA).
GSK notified the Commission of its intention to acquire Pfizer's Consumer Health Business on 17 May 2019. At the end of its initial investigation, the Commission was...